Logo image of GCTS

GCT SEMICONDUCTOR HOLDING IN (GCTS) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:GCTS - US36170N1072 - Common Stock

1.24 USD
-0.05 (-3.88%)
Last: 12/22/2025, 8:04:00 PM
1.24 USD
0 (0%)
After Hours: 12/22/2025, 8:04:00 PM
Fundamental Rating

1

GCTS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 113 industry peers in the Semiconductors & Semiconductor Equipment industry. GCTS has a bad profitability rating. Also its financial health evaluation is rather negative. GCTS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GCTS has reported negative net income.
In the past year GCTS has reported a negative cash flow from operations.
GCTS Yearly Net Income VS EBIT VS OCF VS FCFGCTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

1.2 Ratios

The Return On Assets of GCTS (-162.01%) is worse than 96.46% of its industry peers.
Industry RankSector Rank
ROA -162.01%
ROE N/A
ROIC N/A
ROA(3y)-64.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GCTS Yearly ROA, ROE, ROICGCTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

GCTS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GCTS Yearly Profit, Operating, Gross MarginsGCTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

GCTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GCTS has been increased compared to 1 year ago.
GCTS has a better debt/assets ratio than last year.
GCTS Yearly Shares OutstandingGCTS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
GCTS Yearly Total Debt VS Total AssetsGCTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

GCTS has an Altman-Z score of -41.27. This is a bad value and indicates that GCTS is not financially healthy and even has some risk of bankruptcy.
GCTS has a Altman-Z score of -41.27. This is amonst the worse of the industry: GCTS underperforms 86.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -41.27
ROIC/WACCN/A
WACC11.24%
GCTS Yearly LT Debt VS Equity VS FCFGCTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

GCTS has a Current Ratio of 0.25. This is a bad value and indicates that GCTS is not financially healthy enough and could expect problems in meeting its short term obligations.
GCTS has a worse Current ratio (0.25) than 97.35% of its industry peers.
A Quick Ratio of 0.23 indicates that GCTS may have some problems paying its short term obligations.
GCTS has a Quick ratio of 0.23. This is amonst the worse of the industry: GCTS underperforms 97.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.23
GCTS Yearly Current Assets VS Current LiabilitesGCTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

GCTS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.42%.
Looking at the last year, GCTS shows a very negative growth in Revenue. The Revenue has decreased by -66.24% in the last year.
EPS 1Y (TTM)-94.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.25%
Revenue 1Y (TTM)-66.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-83.52%

3.2 Future

Based on estimates for the next years, GCTS will show a very strong growth in Earnings Per Share. The EPS will grow by 33.75% on average per year.
Based on estimates for the next years, GCTS will show a very strong growth in Revenue. The Revenue will grow by 106.53% on average per year.
EPS Next Y-213.33%
EPS Next 2Y-36.63%
EPS Next 3Y10.97%
EPS Next 5Y33.75%
Revenue Next Year-63.73%
Revenue Next 2Y117.64%
Revenue Next 3Y121.59%
Revenue Next 5Y106.54%

3.3 Evolution

GCTS Yearly Revenue VS EstimatesGCTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 50M 100M 150M
GCTS Yearly EPS VS EstimatesGCTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GCTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GCTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GCTS Price Earnings VS Forward Price EarningsGCTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GCTS Per share dataGCTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.63%
EPS Next 3Y10.97%

More info and screens

0

5. Dividend

5.1 Amount

GCTS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

GCT SEMICONDUCTOR HOLDING IN

NYSE:GCTS (12/22/2025, 8:04:00 PM)

After market: 1.24 0 (0%)

1.24

-0.05 (-3.88%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-23 2026-03-23
Inst Owners13.73%
Inst Owner Change-15.13%
Ins Owners4.58%
Ins Owner Change6.43%
Market Cap70.80M
Revenue(TTM)3.89M
Net Income(TTM)-39.33M
Analysts82.86
Price Target4.08 (229.03%)
Short Float %4.85%
Short Ratio8.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-55.54%
Min EPS beat(2)-82.07%
Max EPS beat(2)-29%
EPS beat(4)1
Avg EPS beat(4)-32.51%
Min EPS beat(4)-82.07%
Max EPS beat(4)28.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-57.07%
Min Revenue beat(2)-64.52%
Max Revenue beat(2)-49.62%
Revenue beat(4)0
Avg Revenue beat(4)-50.51%
Min Revenue beat(4)-74.04%
Max Revenue beat(4)-13.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-61.11%
EPS NY rev (1m)-20.51%
EPS NY rev (3m)-20.51%
Revenue NQ rev (1m)4.25%
Revenue NQ rev (3m)4.25%
Revenue NY rev (1m)-17.74%
Revenue NY rev (3m)-17.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.19
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0.07
BVpS-1.4
TBVpS-1.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -162.01%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-64.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 728.16%
Cap/Sales 38.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.23
Altman-Z -41.27
F-Score2
WACC11.24%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.25%
EPS Next Y-213.33%
EPS Next 2Y-36.63%
EPS Next 3Y10.97%
EPS Next 5Y33.75%
Revenue 1Y (TTM)-66.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-83.52%
Revenue Next Year-63.73%
Revenue Next 2Y117.64%
Revenue Next 3Y121.59%
Revenue Next 5Y106.54%
EBIT growth 1Y-26.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-195.81%
EBIT Next 3Y23.29%
EBIT Next 5Y45.33%
FCF growth 1Y-825.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-774.83%
OCF growth 3YN/A
OCF growth 5YN/A

GCT SEMICONDUCTOR HOLDING IN / GCTS FAQ

What is the fundamental rating for GCTS stock?

ChartMill assigns a fundamental rating of 1 / 10 to GCTS.


What is the valuation status of GCT SEMICONDUCTOR HOLDING IN (GCTS) stock?

ChartMill assigns a valuation rating of 0 / 10 to GCT SEMICONDUCTOR HOLDING IN (GCTS). This can be considered as Overvalued.


How profitable is GCT SEMICONDUCTOR HOLDING IN (GCTS) stock?

GCT SEMICONDUCTOR HOLDING IN (GCTS) has a profitability rating of 0 / 10.


Can you provide the financial health for GCTS stock?

The financial health rating of GCT SEMICONDUCTOR HOLDING IN (GCTS) is 0 / 10.